Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1627179rdf:typepubmed:Citationlld:pubmed
pubmed-article:1627179lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:1627179lifeskim:mentionsumls-concept:C0001056lld:lifeskim
pubmed-article:1627179lifeskim:mentionsumls-concept:C0032150lld:lifeskim
pubmed-article:1627179lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:1627179pubmed:issue1lld:pubmed
pubmed-article:1627179pubmed:dateCreated1992-8-13lld:pubmed
pubmed-article:1627179pubmed:abstractTextAsexual blood forms of the human malaria parasite, Plasmodium falciparum, synthesize a major glycosylated 195 kDa protein that has been considered for the development of a vaccine. beta-Elimination-borohydride reduction of the 195 kDa glycoprotein and its 16 kDa processed product after metabolic labeling of their carbohydrates, showed the presence of derived, labeled glucosaminitol and alanine. This suggests that the 195 and 16 kDa glycoproteins contain distinct O-glycosyl linkages and that N-acetylglucosamine and serine residues are involved in the attachment of carbohydrate moieties to the protein core. Endo-O-glycanase treatment of total glycoproteins shows that O-glycosidycally-linked sugars represent a major carbohydrate moiety in P. falciparum glycoproteins.lld:pubmed
pubmed-article:1627179pubmed:languageenglld:pubmed
pubmed-article:1627179pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1627179pubmed:citationSubsetIMlld:pubmed
pubmed-article:1627179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1627179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1627179pubmed:statusMEDLINElld:pubmed
pubmed-article:1627179pubmed:monthJunlld:pubmed
pubmed-article:1627179pubmed:issn0158-5231lld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:Nasir-ud-Dinlld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:HoessliDDlld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:HuB HBHlld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:Del GiudiceGGlld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:DecrindCClld:pubmed
pubmed-article:1627179pubmed:authorpubmed-author:Drager-DayalR...lld:pubmed
pubmed-article:1627179pubmed:issnTypePrintlld:pubmed
pubmed-article:1627179pubmed:volume27lld:pubmed
pubmed-article:1627179pubmed:ownerNLMlld:pubmed
pubmed-article:1627179pubmed:authorsCompleteYlld:pubmed
pubmed-article:1627179pubmed:pagination55-64lld:pubmed
pubmed-article:1627179pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:meshHeadingpubmed-meshheading:1627179-...lld:pubmed
pubmed-article:1627179pubmed:year1992lld:pubmed
pubmed-article:1627179pubmed:articleTitlePlasmodium falciparum synthesizes O-glycosylated glycoproteins containing O-linked N-acetylglucosamine.lld:pubmed
pubmed-article:1627179pubmed:affiliationWorld Health Organization-Immunology Research Training Centre, Centre Médical Universitaire, Geneva, Switzerland.lld:pubmed
pubmed-article:1627179pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1627179pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed